Table 1

Clinicopathological characteristics of study cases

Clinicopathological characteristicS1 study sectionsS2, S3, S4, G1, and perlecan studies
Median (range) age (yrs)
 Normal ovary56 (55–79)56 ( 55–79)
 Benign ovarian tumors56 (37–73)57 (37–73)
 Borderline ovarian tumors62 (20–77)62 (20–77)
 Epithelial ovarian carcinoma56 (23–80)59 (23–80)
Histological type (n)
 Normal ovary124
 Benign epithelial ovariantumor1010
  Endometrioid11
  Mucinous55
  Serous44
 Borderline ovarian tumor1010
  Mucinous44
  Serous66
 Epithelial ovarian carcinoma11565
  Adenocarcinoma2710
  Clear cell82
  Endometrioid2318
  Mucinous77
  Serous5028
Tumor grade (n)
 Well differentiated1813
 Moderately differentiated2915
 Poorly differentiated5735
 Not known112
FIGO stage (n)
 I96
 II106
 III6536
 IV3117
Residual disease (n)
 None10
 Minimal residual disease(<2 cm)4529
 Bulk disease6936
KP (n)
 >70%7441
 30–70%3623
 Unknown51
 Median8080
  • Abbreviations: S1 through -4, syndecan-1 through -4; G1, glypican-1; FIGO, International Federation of Gynecologists and Obstetricians; KP, Karnowsky performance.